chenodeoxycholic acid has been researched along with angiotensinogen in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daitoku, H; Fujii, H; Fukamizu, A; Hirota, K; Ishida, J; Kato, H; Matsuoka, T; Nangaku, M; Saito, T; Shimamoto, Y; Takeda, J; Yamagata, K | 1 |
1 other study(ies) available for chenodeoxycholic acid and angiotensinogen
| Article | Year |
|---|---|
Inhibitory effect of the small heterodimer partner on hepatocyte nuclear factor-4 mediates bile acid-induced repression of the human angiotensinogen gene.
Topics: Angiotensinogen; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Bile Acids and Salts; Binding Sites; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Cholic Acid; DNA; DNA-Binding Proteins; Female; Gene Expression; Gene Expression Regulation; HeLa Cells; Hepatocyte Nuclear Factor 4; Humans; Liver; Luciferases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis; Phosphoproteins; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Recombinant Proteins; RNA, Messenger; Transcription Factors; Transfection; Tumor Cells, Cultured | 2004 |